Coronary artery disease and human immunodeficiency virus

被引：0

作者：

Sharma, Tushar ^{[1
]}

Sharma, Bhavina ^{[1
]}

Chaudhary, Rahul ^{[2
]}

Faraday, Nauder ^{[3
]}

Goldsweig, Andrew M. ^{[1
,4
,5
]}

机构：

[1] Univ Nebraska Med Ctr, 4400 Emile St, Omaha, NE 68105 USA

[2] Univ Pittsburgh, Med Ctr, Heart & Vasc Inst, Pittsburgh, PA USA

[3] Johns Hopkins Univ, Sch Med, Baltimore, MD USA

[4] Univ Massachusetts Baystate, Baystate Med Ctr, Div Cardiovasc Med, Springfield, MA USA

[5] Univ Massachusetts Baystate, Div Cardiovasc Med, Springfield, MA USA

来源：

CURRENT PROBLEMS IN CARDIOLOGY | 2025年 / 50卷 / 09期

关键词：

Human immunodeficiency virus; Coronary artery disease; Anti-retroviral therapy; HIV-INFECTED PATIENTS; C-REACTIVE PROTEIN; ACTIVE ANTIRETROVIRAL THERAPY; CARDIOVASCULAR RISK-FACTORS; REVERSE-TRANSCRIPTASE INHIBITORS; ACUTE MYOCARDIAL-INFARCTION; INTIMA-MEDIA THICKNESS; ENDOTHELIAL ACTIVATION MARKERS; FRENCH-HOSPITAL-DATABASE; TYPE-2; DIABETES-MELLITUS;

D O I：

10.1016/j.cpcardiol.2025.103101

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Cardiac complications in individuals infected with the human immunodeficiency virus (HIV) have been recognized since the 1980s. However, the type of cardiac conditions seen in this population has changed substantially since the introduction of antiretroviral therapy (ART). Coronary artery disease (CAD) has emerged as a leading cause of morbidity and mortality in HIV positive individuals. HIV and ART have both been linked to the development of CAD through multiple mechanisms. There is limited specific guidance for management of CAD and its risk factors in people with HIV. This literature review explores the pathophysiology and management of CAD in HIV-infected patients, identifying gaps in evidence and areas for future research to address the growing burden of CAD in this patient population.

引用

页数：14